Vocxi Health and S3 Connected Health partner on lung cancer screening and monitoring

Vocxi Health, a pioneering breath diagnostics firm dedicated to precise and non-intrusive disease identification, has entered into a strategic collaboration with S3 Connected Health, a specialised digital health partner catering to life science enterprises. This partnership aims to introduce revolutionary technology to the market, poised to revolutionise the landscape of lung cancer detection and monitoring.

Vocxi Health boasts proprietary patented technology, manifesting as the innovative BreathEZ device. This ingenious apparatus is designed to discern the presence of lung cancer through the analysis of volatile organic compounds in a mere minute of breath sampling. This groundbreaking scientific advancement strives to relegate belated-stage diagnoses to history, holding the promise of earlier identification and enhanced patient outcomes. With lung cancer claiming more than 1.8 million lives globally each year, the potential for a 10-fold survival rate improvement via early detection is substantial.

In a strategic alignment, Vocxi Health has partnered with S3 Connected Health, who will orchestrate the comprehensive end-to-end delivery of their digital health solution. Central to this collaboration is the utilisation of S3 Connected Health's digital health platform, Affinial, renowned as the most encompassing platform available for life science entities seeking to develop regulated digital health solutions. This robust foundation will underpin the development of a bespoke mobile application and cloud-based system. Notably, the Affinial platform's efficiencies in scaling solutions are anticipated to play a pivotal role in accommodating Vocxi Health's future ambitions for the BreathEZ technology, including the potential extension into other medical domains.

Bill Betten, spearheading medtech solutions at S3 Connected Health and closely engaged with Vocxi, expressed his enthusiasm, stating, "Our partnership with Vocxi embarks on an exhilarating journey. This transformative product optimally leverages our capabilities in the digital health domain, including swift deployment facilitated by the Affinial platform, all the while establishing a solid foundation for future expansion congruent with Vocxi's strategic vision."

Randy Schiestl, Chief Operating Officer and board director at Vocxi Health affirmed, "Armed with proprietary technology, a seasoned and motivated core team, trusted advisors, and a global network of partners, Vocxi stands prepared to attain its commercialisation milestones. Our collaboration with S3 Connected Health empowers us to seamlessly integrate mobile and cloud connectivity, instilling a sense of assurance in our pursuits."

Click here to read the original news story.